Key Metrics of Nano-X Imaging Ltd
Revenue$9.9M▲ 15.5% YoYFY 2023
Operating income−$62.6M▲ 46.8% YoY
Net profit−$60.8M▲ 46.3% YoY
Shareholders' equity$196M
Market cap$24.0MNNOX · $0.31
Competitors10identified
About Nano-X Imaging Ltd
Sectors
Company details
- Founded
- 2020
- Listed
- Nasdaq: NNOX (since 2020)
Operational Areas of Nano-X Imaging Ltd
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameNANO-X IMAGING LTD
TickerNNOX
ExchangeNasdaq
CountryIsrael
SEC CIK0001795251
Listed since2020
IndustryMedical Electronics
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
NNOX · Nasdaq · SEC CIK 0001795251
Last price · 30 Oct 2026
$0.31
−4.82%
Market cap$24.0M
P/E—On FY 2023 diluted EPS
Volume1,250,165
SectorHealth CareMedical Electronics
Country · IPOIsraelListed 2020
NNOX share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Nano-X Imaging Ltd
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.